Unlike other bone grafts that are infused with proteins, such as BMP-2, 3ZM does not contain any protein cargo. Instead, the collagen-based graft is already highly osteogenic. Consequently, 3ZM-based bone recovery is less susceptible to bone growth outside the injury site, which has been an unwanted side effect of current FDA-approved grafts. Furthermore, 3ZM is pliable and can be easily sutured to the location of bone damage, and the material dissolves as the bone heals, leaving no trace other than a healed bone.